Interferon gamma biosimilar (Livzon Pharmaceutical Group)

干扰素γ生物类似药 (Livzon Pharmaceutical Group)

Report date: 2022/02/17 13:45:35

Base Information

Drug NameInterferon gamma biosimilar (Livzon Pharmaceutical Group)
Drug Alias Name干扰素γ生物仿制药 (Livzon Pharmaceutical Group)
ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterferon gamma receptor stimulants
TargetsInterferon gamma receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsArthritis, Rheumatoid
Approved Indications in ChinaArthritis, Rheumatoid
Original Approved Country/TerritoryMainland China
Original Approved Date1998/01/01
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesLivzon Pharmaceutical Group Inc
China Registration ClassN/A

Develop Information

Active CompaniesLivzon Pharmaceutical Group Inc
Inactive CompaniesN/A
Active IndicationsArthritis, Rheumatoid
Inactive IndicationsN/A

Other Information

ATC CodeL03AB03
Related LinksN/A